UMIN-CTR Clinical Trial

Recruitment status No longer recruiting
Unique ID issued by UMIN UMIN000005629
Receipt No. R000006653
Scientific Title Pregnancy Associated Cardiomyopathy and Hypertension-Essential Research
Date of disclosure of the study information 2011/05/26
Last modified on 2020/12/28 (Ver. 12)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Pregnancy Associated Cardiomyopathy and Hypertension-Essential Research
Acronym PREACHER
Scientific Title Pregnancy Associated Cardiomyopathy and Hypertension-Essential Research
Scientific Title:Acronym PREACHER
Region
Japan

Condition
Condition Peripartum Cardiomyopathy and Pregnancy Associated Cardiomyopathy
Classification by specialty
Cardiology Obsterics and gynecology
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 Although peripartum cardiomyopathy and pregnancy associated cardiomyopathy are life-threatening cardiomyopathy, little was known about the characteristics of this disease in Japan. We performed a nationwide questionnaire survey of PPCM cases in 2007 and 2008 and incidence (1/20,000 deliveries), risk factors (age, complication of hypertension, multiple births, and tocolytic therapy), and several clinical problems became clear. In this prospective study, we investigate further about detail medical histories, risk factors (especialy hypertension), long term outcomes, treatment, and laboratory parameters.
Basic objectives2 Others
Basic objectives -Others Clinical epidemiology research
Trial characteristics_1 Exploratory
Trial characteristics_2 Pragmatic
Developmental phase Not applicable

Assessment
Primary outcomes -One year follow-up
(at diagnosis, 1-2 weeks later, 3 months later, 6 monthes later, 1 year later)

-medical history
-in cases with hypertension
details of clinical course of pregnancy
-vitals
-ECG
-UCG
-laboratory data
Key secondary outcomes

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit

Not applicable
Age-upper limit

Not applicable
Gender Female
Key inclusion criteria (1) Development of heart failure during pregnancy or within the first 5 postpartum months
(2) No determinable etiology for cardiac failure
(3) No history of heart disease prior to pregnancy
(4) Reduced left ventricular contraction based on a left ventricular ejection fraction (LVEF) <50%
Key exclusion criteria not applicable above
Target sample size 100

Research contact person
Name of lead principal investigator
1st name Tomoaki
Middle name
Last name Ikeda
Organization Mie University Graduate School of Medicine
Division name Department of Obstetrics and Gynecology
Zip code 5140001
Address 2-174 Edobashi, Tsu, MIE
TEL 059-232-1111
Email t-ikeda@clin.medic.mie-u.ac.jp

Public contact
Name of contact person
1st name Chizuko
Middle name
Last name Kamiya
Organization National Cerebral and Cardiovascular Center
Division name The clinical investigation group for peripartum cardiomyopathy
Zip code 5658564
Address 6-1kishibeshinmachi, Suita, Osaka Japan
TEL 06-6170-1070
Homepage URL
Email ppcm@ncvc.go.jp

Sponsor
Institute National Cerebral and Cardiovascular Center
Institute
Department

Funding Source
Organization National Cerebral and Cardiovascular Center
Organization
Division
Category of Funding Organization Other
Nationality of Funding Organization Japan

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization National Cerebral and Cardiovascular Center
Address 6-1 Kishibeshinmachi Suita, Osaka Japan
Tel 06-6170-1070
Email chiz@ncvc.go.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions 国立循環器病研究センター(大阪府)、症例登録施設

Other administrative information
Date of disclosure of the study information
2011 Year 05 Month 26 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status No longer recruiting
Date of protocol fixation
2010 Year 10 Month 22 Day
Date of IRB
2010 Year 10 Month 22 Day
Anticipated trial start date
2010 Year 10 Month 22 Day
Last follow-up date
2020 Year 03 Month 31 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information Prospective study

Management information
Registered date
2011 Year 05 Month 23 Day
Last modified on
2020 Year 12 Month 28 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000006653